Harness Dickey
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • IP Atlas
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation.  Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.

  • All Categories

      ALL CATEGORIES

      • Biologics & Biosimilars
        • Competitor Dynamics
        • FDA Guidance & Updates
        • Interchangeability
      • BioPharma
      • Chemistry & Nanotechnology
      • Featured
      • Harnessing the Lessons of IP
      • IP Management
      • IPR-PGR
      • Licensing
      • Litigation
      • Patent Prosecution
      • Trademarks
  • 2011
    • All Years
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Tyson B. BensonTyson B. Benson 2
    • Jewell N. BriggsJewell N. Briggs 5
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 1
    • Matthew L. CutlerMatthew L. Cutler 15
    • Donald J. DaleyDonald J. Daley 1
    • Darin W. DeaverDarin W. Deaver 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 6
    • Monte L. FalcoffMonte L. Falcoff 1
    • Glenn E. ForbisGlenn E. Forbis 11
    • Mark A. Frentrup, Ph.D.Mark A. Frentrup, Ph.D. 3
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 7
    • Damian H. Kotsis, Ph.D.Damian H. Kotsis, Ph.D. 4
    • Kisuk LeeKisuk Lee 1
    • Robert J. LenihanRobert J. Lenihan 1
    • Jeoyuh LinJeoyuh Lin 1
    • Chris K. MillerChris K. Miller 1
    • John E. MunroJohn E. Munro 1
    • Michael R. NyeMichael R. Nye 1
    • Joshua A. PartingtonJoshua A. Partington 2
    • Leanne M. RakersLeanne M. Rakers 15
    • Derek RichmondDerek Richmond 1
    • Douglas A. RobinsonDouglas A. Robinson 15
    • Joel R. SamuelsJoel R. Samuels 10
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 15
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 11
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3

  • August 13, 2018

    Trademark Registration – A Vehicle to Protection

    More

  • photo of laboratory and scientist creating biosimilar patents

    August 9, 2018

    FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition

    More

  • image of light bulb to suggest hypothetical biosimilar case study

    August 9, 2018

    At Risk Launch: A Hypothetical Case Study

    More

  • photo of chess pieces representing biosimilar competitive dynamics

    August 8, 2018

    Competitor Influence on the Conduct of the Patent Dance and Litigation

    More

  • photo of biosimilar medications

    August 7, 2018

    Seeking Biosimilar Market Entry When a Competitor is Pursuing Interchangeability: Factors to Consider

    More

  • August 3, 2018

    Undue Process: You Can Ask the USPTO to Review a Patent, but if They Blow it, You may be Powerless to Appeal

    More

October 31, 2011

ADAPTING TO PATENT REFORM

By:

IPR-PGR.com

Matt Cutler’s Professional Blog: Harnessing Patent Office Litigation: A Comprehensive Guide to Inter Partes Review and Post Grant Review Proceedings

August 22, 2011

CyberSource v. Retail Decisions, Inc.

By:

August 18, 2011

The Cost of Sloppy Claim Drafting

By:

August 11, 2011

CAFC MYRIAD DECISION: This is Not a “Gene Patent” Case

By:

July 26, 2011

USPTO Proposes Amending Rule 1.56 To Define Materiality In Accordance With Therasense

By: Bryan K. Wheelock, Principal

July 20, 2011

Launch of .XXX Domain Names – Blocking Registration of Trademarks as Domains

By:

June 17, 2011

Does the Federal Circuit “mean” it this time? Adding confusion to when claim language lacking the word “means” should be subject to means-plus-function analysis.

By:

June 17, 2011

A possibility among a limited number is not necessarily a predictable solution; teaching away need not be specific.

By:

June 10, 2011

Microsoft Corp. v. i4i Limited Partnership, U.S., No. 10-290 (June 9, 2011).

By:

June 10, 2011

Stanford v. Roche Molecular Systems, Inc.

By:

June 2, 2011

Global-Tech Appliances, Inc. v. SEB SA – The Supreme Court Addresses Inducement of Patent Infringement

By:

May 27, 2011

Therasense’s Stringent Inequitable Conduct Test

By:

May 4, 2011

TTAB: Prompt Filing of Supplemental Response Cures Procedural Deficiency in Expert Disclosures

By:

April 25, 2011

TiVo Inc. v. Echostar Corp.

By:

April 22, 2011

Providing Support for Generous Construction of a Claimed Range

By:

April 18, 2011

Federal Circuit Overturns Precedential BPAI Opinion, Allows Reissue Only to Add Dependent Claims

By:

April 15, 2011

Harness Dickey Ranks in Top 5 of U.S. Patent Firms

By:

April 8, 2011

Innovention Toys, LLC, V. MGA Entertainment, Inc.

By:

April 8, 2011

THE ORAL ARGUMENT IN MYRIAD, April 4th, 2011

By:

April 7, 2011

The Sin of Synonyms

By:

Posts navigation

1 2 Load more posts

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2018 Harness, Dickey & Pierce, P.L.C. All rights reserved.